09:05 AM EDT, 09/30/2025 (MT Newswires) -- LENZ Therapeutics ( LENZ ) said Tuesday that VIZZ aceclidine ophthalmic solution 1.44% eye drops for the treatment of presbyopia in adults are now available in the US

Product samples have begun to be distributed to optometrists and ophthalmologists, with commercial shipments to be available through pharmacies by mid-Q4, the company said.

LENZ shares were up 2.6% in recent premarket activity.